buprenorphine (pain) vs carbamazepine
PlainMeds reviewed this comparison against our methodology in August 2026. It places FDA and CMS record fields side by side, without recommending either medication.
Side-by-side comparison of buprenorphine (pain) and carbamazepine. Data from FDA drug databases (Orange Book, NDC Directory, recalls, shortages) covering 20,000+ approved drugs, plus CMS pricing; see our methodology.
minor Known Drug Interaction
Examples: Rifampin, carbamazepine, phenytoin Serotonergic Drugs Clinical Impact: The concomitant use of opioids with other drugs that affect the serotonergic neurotransmitter system has resulted in serotonin syndrome.
Belbuca, Butrans
Tegretol
Belbuca is a medicine used to treat severe, long-lasting pain. It contains buprenorphine, a type of opioid pain reliever.
Carbamazepine is a medicine used to control seizures and treat nerve pain. It works by reducing abnormal electrical activity in the brain and calming nerve signals.
Belbuca is used to manage severe, ongoing pain that needs an opioid medicine. It is for pain that cannot be well-treated with other options, like immediate-release opioids. Because of the risks of addiction, abuse, misuse, overdose, and death, Belbuca should only be used if other treatments don't work, aren't tolerated, or aren't enough to manage your pain.
Carbamazepine is used to treat certain types of seizures, including partial seizures and generalized tonic-clonic seizures. It can also treat mixed seizure patterns. Carbamazepine also treats the pain from trigeminal neuralgia, a nerve disorder that causes intense facial pain. It is also sometimes used for glossopharyngeal neuralgia.
Belbuca contains buprenorphine, which is a partial opioid agonist. It works by attaching to certain receptors in the brain and body. This helps to decrease the feeling of pain.
Carbamazepine is an anticonvulsant. It works by reducing the spread of seizure activity in the brain. It also stabilizes nerve impulses to reduce pain.
- • Nausea
- • Constipation
- • Headache
- • Vomiting
- • Dizziness
- • Dizziness
- • Drowsiness
- • Unsteadiness
- • Nausea
- • Vomiting
No adverse event reports.
- Seizure 3,609
- Drug Interaction 3,369
- Fall 3,044
- Dizziness 2,862
- Pyrexia 2,689
Belbuca can lead to addiction, abuse, and misuse, which can result in overdose and death. It can also cause serious, life-threatening breathing problems, especially when you first start taking it or after a dose increase. Accidental exposure, especially in children, can be fatal. Taking Belbuca with benzodiazepines (like Xanax or Valium) or other depressants (including alcohol) can cause severe sleepiness, breathing problems, coma, and death. If you are pregnant and use Belbuca for a long time, your baby could have withdrawal symptoms after birth.
Carbamazepine can cause severe skin reactions, including Stevens-Johnson syndrome (SJS) and toxic epidermal necrolysis (TEN), which can be fatal. If you are of Asian descent, you may need a blood test before starting this medicine. Carbamazepine can also cause serious blood problems like aplastic anemia and agranulocytosis. Contact your doctor right away if you develop a fever, sore throat, rash, or unusual bleeding or bruising.
Using Belbuca for a long time during pregnancy can cause withdrawal symptoms in the newborn. Talk to your doctor if you are pregnant or plan to become pregnant. Breastfeeding is not recommended while using Belbuca.
Carbamazepine may harm an unborn baby. Talk to your doctor if you are pregnant or plan to become pregnant. It is not known if carbamazepine passes into breast milk, so talk to your doctor about breastfeeding.
Also Compare, Nearby Drugs
Compare buprenorphine (pain) with
Compare carbamazepine with
How to Read This buprenorphine (pain) vs carbamazepine Comparison
buprenorphine (pain) is classified in the Partial Opioid Agonist drug class, while carbamazepine sits within the Anticonvulsant class. Drugs from different classes work through distinct mechanisms, so a head-to-head comparison illustrates trade-offs rather than equivalence. Both drugs are prescription-only, so a licensed provider must authorize use.
Adverse event totals above are pulled from the FDA's Adverse Event Reporting System (FAERS). For these top-ranked reactions alone, buprenorphine (pain) has 0 submissions while carbamazepine has 15,573. Those figures reflect cumulative reporting volume, not per-patient risk, so older, widely dispensed drugs typically look worse on count alone. These two drugs have a known minor interaction flagged in FDA labeling, attributed to using these two drugs together can affect a brain chemical called serotonin, which may lead to a serious condition called serotonin syndrome.. Serious warnings, pregnancy guidance, and contraindications can differ even when indications overlap.
A table cannot represent individual circumstances. Data here is sourced from FDA Structured Product Labels (SPL) and FAERS, both of which update as manufacturers and clinicians submit new information. This registry does not provide medical, treatment, substitution, or medication-change directions for buprenorphine (pain) or carbamazepine.
Registry boundary: This comparison displays source-record fields and does not provide individualized medical direction.